BACKGROUNDGiant cell arteritis (GCA), or temporal arteritis, is a chronic vasculitis of medium and large vessel, that usually affects patients over 50 years, and it is more common in women. It is a rare disease, with a variety of differential diagnosis. Without a correct diagnosis and treatment, it can lead to poor evolution and loss of quality of life.
CASE REPORTPatient PFMN, 60 years old, male, retired military, presented with pain in the face, associate with nasal congestion, chewing pain, myalgia in the lower body. Initially, diagnosed with bacterial sinusitis and treated with oral antibiotics for 7 days, without improvement in symptoms. Associated with these symptoms, appeared frontal and temporal headache, being treated with another cycle of IV antibiotics, but with persistence of symptoms. Inflammatory tests were high (erythrocyte sedimentation rate [ESR] 120 mm/h; C-reactive protein [CRP] 18.54 mg/dL). Computed tomography showed no evidence of complicated sinusitis, chest and skull tomography without alterations. Doppler ultrasound of the temporal arteries was performed, which visualized an image of a periluminal hypoechoic halo (target image) in the right temporal artery, suggestive of temporal arteritis. Temporal artery biopsy was performed for histopathological confirmation. Treatment with corticosteroids was initiated with significant improvement in symptoms and inflammatory tests (ESR: 43 mm/h; CRP: 1.36 mg/dL).
CONCLUSIONTemporal arteritis is a possible differential diagnosis to be considered to chronic sinusitis. In some cases, the complaint can be interpreted as infection of the superior airway, which can lead to delay in the diagnosis and appropriate therapy institution.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.